Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Michael Staehler, MD, PhD, Ludwig Maximilian University of Munich, Munich, Germany, discusses the CASSIOPE study (NCT03419572), assessing the use of cabozantinib for the treatment of advanced renal cell carcinoma (RCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.